^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

NK/γδ T cell-enriched cell therapy

i
Other names: NK/γδ T cell-enriched cell therapy, allogeneic transplant donor lymphocytes depleted of TCR-αβ T cells & B cells and enriched for NK cells & TCRγδ T cells
Associations
Trials
Company:
Case Comprehensive Cancer Center
Drug class:
NK cell stimulant, γδ TCR modulator
Related drugs:
Associations
Trials